Modulation of AQPs, such as restoring AQP1 and AQP3 levels or function or stabilizing AQP2 to enhance water reabsorption, could prove beneficial in the treatment of loss-of-function aquaporin diseases such as nephrogenic diabetes insipidus (NDI), among others [219,220]. Here, AQP2 is linked to nephrogenic diabetes insipidus.